The nucleolus directly regulates p53 export and degradation

Journal of Cell Biology

Volumn 194, Issue 5, 2011, Pages 689-703

  Boyd, Mark T ^a   Vlatković, Nikolina ^a   Rubbi, Carlos P ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ANIMAL CELL; ARTICLE; BLEACHING; CELL FRACTIONATION; CELL ISOLATION; CELL TRANSPORT; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; HETEROKARYON; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN STABILITY; PROTEIN TRANSPORT; STEADY STATE; TRANSPORT KINETICS; UBIQUITINATION;

3T3 CELLS; ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL FUSION; CELL LINE, TUMOR; CELL NUCLEOLUS; CELL NUCLEUS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLOHEXIMIDE; CYTOPLASM; DEMECOLCINE; DNA DAMAGE; FATTY ACIDS, UNSATURATED; GREEN FLUORESCENT PROTEINS; HUMANS; INTRANUCLEAR SPACE; LEUPEPTINS; MICE; MODELS, BIOLOGICAL; NUCLEOLUS ORGANIZER REGION; PHOTOBLEACHING; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS C-MDM2; RECOMBINANT FUSION PROTEINS; RIBOSOMAL PROTEINS; SUBCELLULAR FRACTIONS; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN; UBIQUITINATION;

EID: 80052634170     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.201105143     Document Type: Article

References (63)

1. Baens, M., H. Noels, V. Broeckx, S. Hagens, S. Fevery, A.D. Billiau, H. Vankelecom, and P. Marynen. 2006. The dark side of EGFP: defective polyubiquitination. PLoS ONE. 1:e54.
2. Bernardi, R., P.P. Scaglioni, S. Bergmann, H.F. Horn, K.H. Vousden, and P.P. Pandolfi. 2004. PML regulates p53 stability by sequestering Mdm2 to the nucleolus. Nat. Cell Biol. 6:665-672.
3. Bhat, K.P., K. Itahana, A. Jin, and Y. Zhang. 2004. Essential role of ribosomal protein L11 in mediating growth inhibition-induced p53 activation. EMBO J. 23:2402-2412.
4. Bonner, W.M., C.E. Redon, J.S. Dickey, A.J. Nakamura, O.A. Sedelnikova, S. Solier, and Y. Pommier. 2008. GammaH2AX and cancer. Nat. Rev. Cancer. 8:957-967.
5. Borer, R.A., C.F. Lehner, H.M. Eppenberger, and E.A. Nigg. 1989. Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell. 56:379-390.
6. Boulon, S., C. Verheggen, B.E. Jady, C. Girard, C. Pescia, C. Paul, J.K. Ospina, T. Kiss, A.G. Matera, R. Bordonné, and E. Bertrand. 2004. PHAX and CRM1 are required sequentially to transport U3 snoRNA to nucleoli. Mol. Cell. 16:777-787.
7. Boyd, S.D., K.Y. Tsai, and T. Jacks. 2000. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53. Nat. Cell Biol. 2:563-568.
8. Brady, M., N. Vlatković, and M.T. Boyd. 2005. Regulation of p53 and MDM2 activity by MTBP. Mol. Cell. Biol. 25:545-553.
9. Brooks, C.L., and W. Gu. 2006. p53 ubiquitination: Mdm2 and beyond. Mol. Cell. 21:307-315.
10. Carter, S., O. Bischof, A. Dejean, and K.H. Vousden. 2007. C-terminal modifications regulate MDM2 dissociation and nuclear export of p53. Nat. Cell Biol. 9:428-435.
11. Chen, D., and S. Huang. 2001. Nucleolar components involved in ribosome biogenesis cycle between the nucleolus and nucleoplasm in interphase cells. J. Cell Biol. 153:169-176.
12. Colombo, E., J.C. Marine, D. Danovi, B. Falini, and P.G. Pelicci. 2002. Nucleophosmin regulates the stability and transcriptional activity of p53. Nat. Cell Biol. 4:529-533.
13. Dai, M.S., and H. Lu. 2004. Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J. Biol. Chem. 279:44475-44482.
14. Dai, M.S., S.X. Zeng, Y. Jin, X.X. Sun, L. David, and H. Lu. 2004. Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. Mol. Cell. Biol. 24:7654-7668.
15. Emmott, E., and J.A. Hiscox. 2009. Nucleolar targeting: the hub of the matter. EMBO Rep. 10:231-238.
16. Finch, R.A., and P.K. Chan. 1996. ATP depletion affects NPM translocation and exportation of rRNA from nuclei. Biochem. Biophys. Res. Commun. 222:553-558.
17. Fontoura, B.M., E.A. Sorokina, E. David, and R.B. Carroll. 1992. p53 is covalently linked to 5.8S rRNA. Mol. Cell. Biol. 12:5145-5151.
18. Fontoura, B.M., C.A. Atienza, E.A. Sorokina, T. Morimoto, and R.B. Carroll. 1997. Cytoplasmic p53 polypeptide is associated with ribosomes. Mol. Cell. Biol. 17:3146-3154.
19. Fornerod, M., M. Ohno, M. Yoshida, and I.W. Mattaj. 1997. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell. 90:1051-1060.
20. Freedman, D.A., and A.J. Levine. 1998. Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6. Mol. Cell. Biol. 18:7288-7293.
21. Geyer, R.K., Z.K. Yu, and C.G. Maki. 2000. The MDM2 RING-finger domain is required to promote p53 nuclear export. Nat. Cell Biol. 2:569-573.
22. Granetto, C., L. Ottaggio, A. Abbondandolo, and S. Bonatti. 1996. p53 accumulates in micronuclei after treatment with a DNA breaking chemical, methylnitrosourea, and with the spindle poison, vinblastine. Mutat. Res. 352:61-64.
23. Gray, L.J., P. Bjelogrlic, V.C.L. Appleyard, A.M. Thompson, C.E. Jolly, S. Lain, and C.S. Herrington. 2007. Selective induction of apoptosis by leptomycin B in keratinocytes expressing HPV oncogenes. Int. J. Cancer. 120:2317-2324.
24. Hernandez-Verdun, D. 2006. Nucleolus: from structure to dynamics. Histochem. Cell Biol. 125:127-137.
25. Hernandez-Verdun, D., M. Robert-Nicoud, G. Geraud, and C. Masson. 1991. Behaviour of nucleolar proteins in nuclei lacking ribosomal genes. A study by confocal laser scanning microscopy. J. Cell Sci. 98:99-105.
26. Horn, H.F., and K.H. Vousden. 2004. Cancer: guarding the guardian? Nature. 427:110-111.
27. Jin, A., K. Itahana, K. O'Keefe, and Y. Zhang. 2004. Inhibition of HDM2 and activation of p53 by ribosomal protein L23. Mol. Cell. Biol. 24:7669-7680.
28. Klibanov, S.A., H.M. O'Hagan, and M. Ljungman. 2001. Accumulation of soluble and nucleolar-associated p53 proteins following cellular stress. J. Cell Sci. 114:1867-1873.
29. Kurki, S., K. Peltonen, L. Latonen, T.M. Kiviharju, P.M. Ojala, D. Meek, and M. Laiho. 2004. Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. Cancer Cell. 5:465-475.
30. Laín, S., C. Midgley, A. Sparks, E.B. Lane, and D.P. Lane. 1999. An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs. Exp. Cell Res. 248:457-472.
31. Lam, Y.W., and A.I. Lamond. 2006. Isolation of nucleoli. In Cell Biology: A Laboratory Handbook. Third edition. Vol. 2. J.E. Celis, editor. Elsevier Academic Press, Amsterdam/Boston. 103-108.
32. Lam, Y.W., A.I. Lamond, M. Mann, and J.S. Andersen. 2007. Analysis of nucleolar protein dynamics reveals the nuclear degradation of ribosomal proteins. Curr. Biol. 17:749-760.
33. Latonen, L., H.M. Moore, B. Bai, S. Jäämaa, and M. Laiho. 2011. Proteasome inhibitors induce nucleolar aggregation of proteasome target proteins and polyadenylated RNA by altering ubiquitin availability. Oncogene. 30:790-805.
34. Leary, D.J., M.P. Terns, and S. Huang. 2004. Components of U3 snoRNAcontaining complexes shuttle between nuclei and the cytoplasm and differentially localize in nucleoli: implications for assembly and function. Mol. Biol. Cell. 15:281-293.
35. Li, M., C.L. Brooks, F. Wu-Baer, D. Chen, R. Baer, and W. Gu. 2003. Monoversus polyubiquitination: differential control of p53 fate by Mdm2. Science. 302:1972-1975.
36. Lippincott-Schwartz, J., N. Altan-Bonnet, and G.H. Patterson. 2003. Photobleaching and photoactivation: following protein dynamics in living cells. Nat. Cell Biol. (Suppl.):S7-S14.
37. Ljungman, M. 2000. Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress. Neoplasia. 2:209-225.
38. Lohrum, M.A., M. Ashcroft, M.H. Kubbutat, and K.H. Vousden. 2000. Identification of a cryptic nucleolar-localization signal in MDM2. Nat. Cell Biol. 2:179-181.
39. Lohrum, M.A., R.L. Ludwig, M.H. Kubbutat, M. Hanlon, and K.H. Vousden. 2003. Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell. 3:577-587.
40. Maguire, M., P.C. Nield, T. Devling, R.E. Jenkins, B.K. Park, R. Polański, N. Vlatković, and M.T. Boyd. 2008. MDM2 regulates dihydrofolate reductase activity through monoubiquitination. Cancer Res. 68:3232-3242.
41. Marchenko, N.D., and U.M. Moll. 2007. The role of ubiquitination in the direct mitochondrial death program of p53. Cell Cycle. 6:1718-1723.
42. Marechal, V., B. Elenbaas, J. Piette, J.-C. Nicolas, and A.J. Levine. 1994. The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes. Mol. Cell. Biol. 14:7414-7420.
43. Marine, J.C., and G. Lozano. 2010. Mdm2-mediated ubiquitylation: p53 and beyond. Cell Death Differ. 17:93-102.
44. Mayer, C., and I. Grummt. 2005. Cellular stress and nucleolar function. Cell Cycle. 4:1036-1038.
45. Mekhail, K., M. Khacho, A. Carrigan, R.R. Hache, L. Gunaratnam, and S. Lee. 2005. Regulation of ubiquitin ligase dynamics by the nucleolus. J. Cell Biol. 170:733-744.
46. Muro, E., T.Q. Hoang, A. Jobart-Malfait, and D. Hernandez-Verdun. 2008. In nucleoli, the steady state of nucleolar proteins is leptomycin B-sensitive. Biol. Cell. 100:303-313.
47. O'Hagan, H.M., and M. Ljungman. 2004. Nuclear accumulation of p53 following inhibition of transcription is not due to diminished levels of MDM2. Oncogene. 23:5505-5512.
48. Olson, M.O. 2004. Sensing cellular stress: another new function for the nucleolus? Sci. STKE. 2004:pe10.
49. Olson, M.O., and M. Dundr. 2005. The moving parts of the nucleolus. Histochem. Cell Biol. 123:203-216.
50. Rubbi, C.P., and J. Milner. 2003. Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. EMBO J. 22:6068-6077.
51. Sablina, A.A., G.V. Ilyinskaya, S.N. Rubtsova, L.S. Agapova, P.M. Chumakov, and B.P. Kopnin. 1998. Activation of p53-mediated cell cycle checkpoint in response to micronuclei formation. J. Cell Sci. 111:977-984.
52. Sherr, C.J., and J.D. Weber. 2000. The ARF/p53 pathway. Curr. Opin. Genet. Dev. 10:94-99.
53. Sleeman, J. 2007. A regulatory role for CRM1 in the multi-directional trafficking of splicing snRNPs in the mammalian nucleus. J. Cell Sci. 120:1540-1550.
54. Sleeman, J.E., P. Ajuh, and A.I. Lamond. 2001. snRNP protein expression enhances the formation of Cajal bodies containing p80-coilin and SMN. J. Cell Sci. 114:4407-4419.
55. Stavreva, D.A., M. Kawasaki, M. Dundr, K. Koberna, W.G. Müller, T. Tsujimura-Takahashi, W. Komatsu, T. Hayano, T. Isobe, I. Raska, et al. 2006. Potential roles for ubiquitin and the proteasome during ribosome biogenesis. Mol. Cell. Biol. 26:5131-5145.
56. Sundqvist, A., G. Liu, A. Mirsaliotis, and D.P. Xirodimas. 2009. Regulation of nucleolar signalling to p53 through NEDDylation of L11. EMBO Rep. 10:1132-1139.
57. Tao, W., and A.J. Levine. 1999a. Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53. Proc. Natl. Acad. Sci. USA. 96:3077-3080.
58. Tao, W., and A.J. Levine. 1999b. P19(ARF) stabilizes p53 by blocking nucleocytoplasmic shuttling of Mdm2. Proc. Natl. Acad. Sci. USA. 96:6937-6941.
59. Tsai, R.Y., and R.D. McKay. 2005. A multistep, GTP-driven mechanism controlling the dynamic cycling of nucleostemin. J. Cell Biol. 168:179-184.
60. Welcker, M., A. Orian, J.E. Grim, R.N. Eisenman, and B.E. Clurman. 2004. A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size. Curr. Biol. 14:1852-1857.
61. Xirodimas, D.P. 2008. Novel substrates and functions for the ubiquitin-like molecule NEDD8. Biochem. Soc. Trans. 36:802-806.
62. Xirodimas, D., M.K. Saville, C. Edling, D.P. Lane, and S. Laín. 2001. Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo. Oncogene. 20:4972-4983.
63. Zhang, Y., G.W. Wolf, K. Bhat, A. Jin, T. Allio, W.A. Burkhart, and Y. Xiong. 2003. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol. Cell. Biol. 23:8902-8912.